Gartner, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2012-09-30 was -1.50M shares.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2012-06-30 was 300.00K shares.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2012-03-31 was 400.00K shares.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2011-12-31 was -2.20M shares.
- Gartner, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2011 was -900.00K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2012-09-30 | -1.50M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -3.00M shares derived: sum of 4 quarters · filed 2013-02-22 |
| 2012-06-30 | 300.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-03 | -1.50M shares derived: sum of 4 quarters · filed 2013-02-22 |
| 2012-03-31 | 400.00K shares 10-Q · filed 2012-05-03 | |
| 2011-12-31 | -2.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-22 | -900.00K shares 10-K · filed 2013-02-22 |
| 2011-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Evolent Health, Inc. (EVH) | United States | $0.397B | -1.21 |
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |